Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Find criteria to select coins worth holding for 5–10 years, focusing on utility, adoption, and resilience against market cycles.
20,995 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Adobe and Duolingo sit at opposite ends of the tech stock spectrum: one is a cash-generating powerhouse, the other a ...
Goldfinch outlines a phased wind-down of its Prime unit, shifting from growth to borrower recoveries and testing whet...
Trump abruptly delays signing the 21st Century ROAD to Housing Act, tying its fate to passage of the SAVE AMERICA ACT...
A dominant market infrastructure firm sits at the heart of capital markets, wielding a legally protected financial mo...
Kraken and Maple launch a pioneering on-chain credit facility that lets institutions borrow against crypto holdings i...
A top Moody’s economist argues AI-related costs are propping up inflation, not damping it. He warns relief won’t arri...
A new analysis shows that retiring to Marco Island at 65 with a $1.5 million nest egg is possible, but only with a pa...
Ethereum slid again as it tests a crucial resistance area, with any short-term recovery fading beneath the larger dow...
Snap is playing a high-stakes game. This article breaks down snap’s specs gamble, what it would take for AR hardware ...
Job seekers are facing increasingly convincing thieves using AI to mimic recruiters and fake interview portals. Exper...
Landlords often overlook insurance until a claim hits. This guide reveals the three biggest mistakes and practical fi...